London startup Perceptic raised $12M to build an AI operating system that unites fragmented pharma R&D workflows, speeding due diligence and clinical translation.
Perceptic’s AI Operating System Raises $12M to Unite Drug Discovery Read More »
QIAGEN and NVIDIA are combining QIAGEN Digital Insights with NVIDIA BioNeMo and graph-based AI to speed target ID, biomarker discovery and drug repurposing.
QIAGEN and NVIDIA Partner to Advance AI Drug Discovery Read More »
Isomorphic Labs raised $2.1 billion to scale its IsoDDE AI drug design engine. Backed by Thrive Capital, Alphabet, Temasek and the UK’s sovereign AI fund, the funding aims to speed therapeutic programs toward clinic.
Isomorphic Labs Secures $2.1B Series B to Accelerate AI Drug Discovery Read More »
How AI is moving from drug discovery into clinical trials, operations and commercial strategy, and why pharma must adopt a holistic, ecosystem view to win.
AI Reshaping Pharma: From Discovery to Strategic Advantage Read More »
Insilico’s AI-discovered Rentosertib (ISM001-055) wins IND for inhalation Phase I in IPF, validating Pharma.AI’s faster, repeatable drug discovery approach.
Rentosertib IND Cleared for Inhalation Study in IPF — AI-Discovered by Insilico Read More »
The Health + AI Insiders Tech Show, hosted by Insiders Intelligence Group, took place yesterday 29 April 2026
at Big Penny Social, London.
That’s a Wrap: The UK’s First Health + AI Tech Show Read More »
Insilico Medicine convenes an industry-first Longevity Board to marry Big Pharma expertise with AI drug discovery, targeting dual-purpose therapies to extend healthspan.
Amazon’s AWS Bio Discovery pairs foundation models, agentic assistants and CRO wet labs to accelerate early-stage drug discovery for pharma and biotech.
Amazon Launches AWS Bio Discovery: AI-Powered ‘Lab-in-the-Loop’ to Speed Drug R&D Read More »
Explore how AI-native Electronic Lab Notebooks convert record-keeping into proactive research assistance, integrating tools and data to accelerate drug discovery.
AI-Native ELNs: How Intelligent Lab Notebooks Speed Drug Discovery Read More »
Latest on Verily’s $300M raise, Latent Labs’ Latent-X2, Insilico’s PandaClaw, and BMS-insitro ALS work. What these moves mean for AI-driven drug discovery.
AI Drug Discovery’s Momentum: Key Updates from the Frontier Read More »
